Memorandum of Agreement (MoA) Signing for Lab-to-Market Collaborative Fund

On  25th November 2020, UKM Technology Sdn Bhd and F2 Bio Sdn Bhd has signed a MoA for Lab-to-Market Collaborative Fund for one of CTERM project in developing Dermal Fibroblast Sera.

Congratulations to all that work hard in translating the research for future public use. 

CENTRE FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE (CTERM)

12th Floor, Clinical Block,
Hospital Canselor Tunku Muhriz (HCTM),
Faculty of Medicine, Jalan Yaa’cob Latiff,
56000 Cheras Kuala Lumpur, MALAYSIA.

Phone: +6 03 9145 7670
Email: ctermfper@ukm.edu.my 

error: Content is protected !!